Holotoxin A₁ Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells

Mar Drugs. 2018 Apr 10;16(4):123. doi: 10.3390/md16040123.

Abstract

Marine triterpene glycosides are attractive candidates for the development of anticancer agents. Holotoxin A₁ is a triterpene glycoside found in the edible sea cucumber, Apostichopus (Stichopus) japonicus. We previously showed that cladoloside C₂, the 25(26)-dihydro derivative of holotoxin A₁ induced apoptosis in human leukemia cells by activating ceramide synthase 6. Thus, we hypothesized that holotoxin A₁, which is structurally similar to cladoloside C₂, might induce apoptosis in human leukemia cells through the same molecular mechanism. In this paper, we compared holotoxin A₁ and cladoloside C₂ for killing potency and mechanism of action. We found that holotoxin A₁ induced apoptosis more potently than cladoloside C₂. Moreover, holotoxin A₁-induced apoptosis in K562 cells by activating caspase-8 and caspase-3, but not by activating caspase-9. During holotoxin A₁-induced apoptosis, acid sphingomyelinase (SMase) and neutral SMase were activated in both K562 cells and human primary leukemia cells. Specifically inhibiting acid SMase and neutral SMаse with chemical inhibitors or siRNAs significantly inhibited holotoxin A₁-induced apoptosis. These results indicated that holotoxin A₁ might induce apoptosis by activating acid SMase and neutral SMase. In conclusion, holotoxin A₁ represents a potential anticancer agent for treating leukemia. Moreover, the aglycone structure of marine triterpene glycosides might affect the mechanism involved in inducing apoptosis.

Keywords: acid sphingomyelinase; apoptosis; leukemia; marine triterpene glycoside; neutral sphingomyelinase.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects*
  • Caspase 3
  • Caspases / metabolism
  • Enzyme Activation / drug effects
  • Female
  • Glycosides / pharmacology*
  • Glycosides / therapeutic use
  • Humans
  • Inhibitory Concentration 50
  • K562 Cells
  • Leukemia / drug therapy*
  • Male
  • Middle Aged
  • Primary Cell Culture
  • RNA, Small Interfering / metabolism
  • Sea Cucumbers*
  • Sphingomyelin Phosphodiesterase / antagonists & inhibitors
  • Sphingomyelin Phosphodiesterase / genetics
  • Sphingomyelin Phosphodiesterase / metabolism*
  • Triterpenes / pharmacology*
  • Triterpenes / therapeutic use

Substances

  • Antineoplastic Agents
  • Glycosides
  • RNA, Small Interfering
  • Triterpenes
  • cladoloside C
  • stichoposide
  • Sphingomyelin Phosphodiesterase
  • CASP3 protein, human
  • Caspase 3
  • Caspases